• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Pipeline Vantage血流导向装置治疗大脑后循环囊状动脉瘤的安全性和有效性

Safety and efficacy of the pipeline vantage flow diverter for the treatment of saccular aneurysms in the posterior cerebral circulation.

作者信息

Abu-Fares Omar, Adamou Antonis, Raab Peter, Lanfermann Heinrich, Sirakov Alexander, Middendorff Marie, Hounchonou Harold F, Krauss Joachim K, Al-Afif Shadi

机构信息

Institute of Diagnostic and Interventional Neuroradiology, Hannover Medical School, Germany.

Radiology Department, UH St Ivan Rilski, Bulgaria.

出版信息

Neuroradiol J. 2025 Aug 27:19714009251373070. doi: 10.1177/19714009251373070.

DOI:10.1177/19714009251373070
PMID:40862644
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12391030/
Abstract

IntroductionPosterior circulation aneurysms are particularly challenging to treat due to their anatomical complexity and the high perforator density within this region. The pipeline vantage flow diverter (PVFD) has shown promising results in treating anterior circulation aneurysms. However, its efficacy and safety in treating posterior circulation saccular aneurysms are not well investigated.MethodsSingle-center study reviewed patients with posterior circulation aneurysms treated with the PVFD between September 2021 and March 2024. Patients and aneurysm characteristics, clinical results, and radiological results were documented.Results22 patients harboring 24 aneurysms were identified. All aneurysms had a saccular morphology. Complications included ischemic events in two patients (8.3%), one leading to mRS deterioration from 0 to 3. One cerebral hemorrhage leading to mRS shift from 0 to 1 was also documented. At the latest imaging follow-up available (median 14.3 months), complete aneurysm occlusion (Class I, Raymond-Roy occlusion classification (RROC) was achieved in 50% of the cases, residual neck (Class II) in 41.7%, and residual aneurysm (Class III) in 8.3%. Basilar bifurcation aneurysms had lower complete occlusion rates (RROC I: 33.3%) and higher complication rates (16.7% with mRS shift) compared to other locations. In-stent stenosis was rare (4.5%). A limitation of the study is the retrospective, single-center study design.ConclusionThe PVFD demonstrates high occlusion rates and a favorable safety profile in the treatment of saccular aneurysms in the posterior circulation. However, treatment of basilar bifurcation aneurysms with the PVFD remains challenging due to the complex anatomy and high-flow dynamics in this location.

摘要

引言

后循环动脉瘤因其解剖结构复杂以及该区域内穿支血管密度高,治疗起来极具挑战性。管道优势血流转向装置(PVFD)在治疗前循环动脉瘤方面已显示出有前景的结果。然而,其在治疗后循环囊状动脉瘤中的疗效和安全性尚未得到充分研究。

方法

单中心研究回顾了2021年9月至2024年3月期间接受PVFD治疗的后循环动脉瘤患者。记录了患者和动脉瘤的特征、临床结果及影像学结果。

结果

共识别出22例患者,其患有24个动脉瘤。所有动脉瘤均为囊状形态。并发症包括2例患者发生缺血事件(8.3%),其中1例导致改良Rankin量表(mRS)评分从0恶化至3。还记录了1例脑出血导致mRS评分从0转变为1。在最新的影像学随访(中位时间14.3个月)时,50%的病例实现了动脉瘤完全闭塞(I级,雷蒙德 - 罗伊闭塞分类(RROC)),41.7%为残余颈部(II级),8.3%为残余动脉瘤(III级)。与其他部位相比,基底动脉分叉处动脉瘤的完全闭塞率较低(RROC I:33.3%),并发症发生率较高(mRS评分转变的为16.7%)。支架内狭窄罕见(4.5%)。本研究的一个局限性是回顾性的单中心研究设计。

结论

PVFD在治疗后循环囊状动脉瘤方面显示出高闭塞率和良好的安全性。然而,由于该部位解剖结构复杂和血流动力学特点,使用PVFD治疗基底动脉分叉处动脉瘤仍然具有挑战性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e817/12391030/00d9937231c9/10.1177_19714009251373070-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e817/12391030/9578ab00c0c0/10.1177_19714009251373070-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e817/12391030/15d0211d4e04/10.1177_19714009251373070-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e817/12391030/00d9937231c9/10.1177_19714009251373070-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e817/12391030/9578ab00c0c0/10.1177_19714009251373070-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e817/12391030/15d0211d4e04/10.1177_19714009251373070-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e817/12391030/00d9937231c9/10.1177_19714009251373070-fig3.jpg

相似文献

1
Safety and efficacy of the pipeline vantage flow diverter for the treatment of saccular aneurysms in the posterior cerebral circulation.Pipeline Vantage血流导向装置治疗大脑后循环囊状动脉瘤的安全性和有效性
Neuroradiol J. 2025 Aug 27:19714009251373070. doi: 10.1177/19714009251373070.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Safety and Efficacy of the Neuroform Atlas Stent for Treatment of Intracranial Aneurysms: A Systematic Review, Meta-Analysis, and Meta-Regression.Neuroform Atlas支架治疗颅内动脉瘤的安全性和有效性:一项系统评价、荟萃分析和Meta回归分析
AJNR Am J Neuroradiol. 2025 Jun 3;46(6):1120-1129. doi: 10.3174/ajnr.A8593.
4
Initial Experience with the Pipeline Vantage Flow Diverter for Intracranial Aneurysms: A Systematic Review and Meta-Analysis.Pipeline Vantage血流导向装置治疗颅内动脉瘤的初步经验:一项系统评价和荟萃分析。
AJNR Am J Neuroradiol. 2025 Mar 4;46(3):510-516. doi: 10.3174/ajnr.A8555.
5
LEO or LEO baby within enterprise overlapping stents combined with coil embolization treatment for ruptured vertebrobasilar artery dissecting aneurysms.在企业重叠支架联合弹簧圈栓塞治疗破裂性椎基底动脉夹层动脉瘤中使用LEO或LEO婴儿型支架
Sci Rep. 2025 Jul 11;15(1):25153. doi: 10.1038/s41598-025-11035-5.
6
Ruptured Posterior Inferior Cerebellar Artery Aneurysms: Integrating Microsurgical Expertise, Endovascular Challenges, and AI-Driven Risk Assessment.小脑后下动脉动脉瘤破裂:整合显微外科专业知识、血管内治疗挑战及人工智能驱动的风险评估
J Clin Med. 2025 Jul 30;14(15):5374. doi: 10.3390/jcm14155374.
7
Endovascular treatment of cerebral aneurysms using flow-diverter devices: A systematic review.使用血流导向装置对脑动脉瘤进行血管内治疗:一项系统评价。
Neuroradiol J. 2015 Aug;28(4):365-75. doi: 10.1177/1971400915602803. Epub 2015 Aug 27.
8
Safety and Effect of Flow Diverters in the Management of Large and Giant Unruptured Intracranial Aneurysms.血流导向装置治疗大型和巨大型未破裂颅内动脉瘤的安全性和疗效
ANZ J Surg. 2025 Jul-Aug;95(7-8):1378-1387. doi: 10.1111/ans.70221. Epub 2025 Jun 27.
9
Endovascular Treatment of Wide-Neck Intracranial Aneurysms Using the Novel Contour Neurovascular System: 5-Year Follow-up.使用新型轮廓神经血管系统对宽颈颅内动脉瘤进行血管内治疗:5年随访
AJNR Am J Neuroradiol. 2025 Jul 1;46(7):1387-1394. doi: 10.3174/ajnr.A8641.
10
Long-term safety and efficacy of the FRED X flow diverter for intracranial aneurysms: a multicenter study of 154 patients.FRED X血流导向装置治疗颅内动脉瘤的长期安全性和有效性:一项对154例患者的多中心研究。
J Neurosurg. 2025 Feb 28;143(1):232-242. doi: 10.3171/2024.10.JNS241233. Print 2025 Jul 1.

本文引用的文献

1
Initial Experience with the Pipeline Vantage Flow Diverter for Intracranial Aneurysms: A Systematic Review and Meta-Analysis.Pipeline Vantage血流导向装置治疗颅内动脉瘤的初步经验:一项系统评价和荟萃分析。
AJNR Am J Neuroradiol. 2025 Mar 4;46(3):510-516. doi: 10.3174/ajnr.A8555.
2
The safety and utility of the semi-sitting position for clipping of posterior circulation aneurysms.半坐位夹闭后循环动脉瘤的安全性和实用性。
Acta Neurochir (Wien). 2024 Aug 20;166(1):341. doi: 10.1007/s00701-024-06229-1.
3
Pipeline Vantage Embolization Device for the treatment of intracranial aneurysms: A systematic review and meta-analysis.
用于治疗颅内动脉瘤的Pipeline Vantage栓塞装置:系统评价与荟萃分析
Interv Neuroradiol. 2024 Jul 25:15910199241264340. doi: 10.1177/15910199241264340.
4
Treatment of intracranial aneurysms with large-diameter (≥5.5 mm) Derivo Embolization Devices, with particular focus on 7 and 8 mm diameter devices.使用大直径(≥5.5毫米)Derivo栓塞装置治疗颅内动脉瘤,尤其关注直径7毫米和8毫米的装置。
Interv Neuroradiol. 2024 May 5:15910199241248479. doi: 10.1177/15910199241248479.
5
Vanguard Study: Initial experience with the new fourth generation Pipeline Vantage Flow Diverter (PVFD): 6-month results, technical and clinical considerations.先锋研究:新型第四代Pipeline Vantage血流导向装置(PVFD)的初步经验:6个月结果、技术及临床考量
J Neurointerv Surg. 2024 Dec 26;17(e1):e166-e171. doi: 10.1136/jnis-2023-021182.
6
Outcome study of the Pipeline Vantage Embolization Device (second version) in unruptured (and ruptured) aneurysms (PEDVU(R) study).Pipeline Vantage 栓塞装置(第二代)治疗未破裂(和破裂)动脉瘤的结果研究(PEDVU(R) 研究)。
J Neurointerv Surg. 2024 Oct 14;16(11):1136-1144. doi: 10.1136/jnis-2023-020754.
7
Early clinical experience with the new generation Pipeline Vantage flow diverter in the treatment of unruptured saccular aneurysms using short-term dual antiplatelet therapy.新一代Pipeline Vantage血流导向装置采用短期双联抗血小板治疗未破裂囊状动脉瘤的早期临床经验。
Interv Neuroradiol. 2023 Oct 5:15910199231205047. doi: 10.1177/15910199231205047.
8
Flow diversion for the treatment of intracranial bifurcation aneurysms: a systematic review and meta-analysis.血流导向装置治疗颅内分叉部动脉瘤:系统评价和荟萃分析。
J Neurointerv Surg. 2024 Aug 14;16(9):921-927. doi: 10.1136/jnis-2023-020582.
9
Early Outcomes of the Pipeline Vantage Flow Diverter : A Multicentre Study.Pipeline Vantage 血流导向装置的早期结果:一项多中心研究。
Clin Neuroradiol. 2023 Dec;33(4):887-896. doi: 10.1007/s00062-023-01314-x. Epub 2023 Jun 28.
10
First clinical multicenter experience with the new Pipeline Vantage flow diverter.新型Pipeline Vantage血流导向装置的首次临床多中心经验。
J Neurointerv Surg. 2023 Jan;15(1):63-69. doi: 10.1136/neurintsurg-2021-018480. Epub 2022 Feb 16.